219 related articles for article (PubMed ID: 9494773)
1. Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan.
Elias CJ; Coggins C; Alvarez F; Brache V; Fraser IS; Lacarra M; Lähteenmäki P; Massai R; Mishell DR; Phillips DM; Salvatierra AM
Contraception; 1997 Dec; 56(6):387-9. PubMed ID: 9494773
[TBL] [Abstract][Full Text] [Related]
2. Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel.
Amaral E; Faúndes A; Zaneveld L; Waller D; Garg S
Contraception; 1999 Dec; 60(6):361-6. PubMed ID: 10715372
[TBL] [Abstract][Full Text] [Related]
3. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Johanson WM; Archer DF
Contraception; 1997 Aug; 56(2):97-102. PubMed ID: 9315418
[TBL] [Abstract][Full Text] [Related]
4. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.
Stafford MK; Ward H; Flanagan A; Rosenstein IJ; Taylor-Robinson D; Smith JR; Weber J; Kitchen VS
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):327-31. PubMed ID: 9525433
[TBL] [Abstract][Full Text] [Related]
5. Vaginal epithelial surface appearances in women using vaginal rings for contraception.
Fraser IS; Lacarra M; Mishell DR; Alvarez F; Brache V; Lähteenmäki P; Elomaa K; Weisberg E; Nash HA
Contraception; 2000 Feb; 61(2):131-8. PubMed ID: 10802278
[TBL] [Abstract][Full Text] [Related]
6. A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Abercrombie TJ; Archer DF
Contraception; 1997 Aug; 56(2):89-96. PubMed ID: 9315417
[TBL] [Abstract][Full Text] [Related]
7. Acceptability of a novel vaginal microbicide during a safety trial among low-risk women.
Bentley ME; Morrow KM; Fullem A; Chesney MA; Horton SD; Rosenberg Z; Mayer KH
Fam Plann Perspect; 2000; 32(4):184-8. PubMed ID: 10942354
[TBL] [Abstract][Full Text] [Related]
8. Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide.
Coggins C; Blanchard K; Alvarez F; Brache V; Weisberg E; Kilmarx PH; Lacarra M; Massai R; Mishell D; Salvatierra A; Witwatwongwana P; Elias C; Ellertson C
Sex Transm Infect; 2000 Dec; 76(6):480-3. PubMed ID: 11221133
[TBL] [Abstract][Full Text] [Related]
9. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
[TBL] [Abstract][Full Text] [Related]
10. Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring.
Bounds W; Szarewski A; Lowe D; Guillebaud J
Eur J Obstet Gynecol Reprod Biol; 1993 Feb; 48(2):123-5. PubMed ID: 8491331
[TBL] [Abstract][Full Text] [Related]
11. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
[TBL] [Abstract][Full Text] [Related]
12. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
[TBL] [Abstract][Full Text] [Related]
13. [Current status of the female condom in Africa].
Deniaud F
Sante; 1997; 7(6):405-15. PubMed ID: 9503499
[TBL] [Abstract][Full Text] [Related]
14. Spermicidal and antiviral properties of cholic acid: contraceptive efficacy of a new vaginal sponge (Protectaid) containing sodium cholate.
Psychoyos A; Creatsas G; Hassan E; Georgoulias V; Gravanis A
Hum Reprod; 1993 Jun; 8(6):866-9. PubMed ID: 7688380
[TBL] [Abstract][Full Text] [Related]
15. WHI-05, a novel bromo-methoxy substituted phenyl phosphate derivative of zidovudine, is a dual-action spermicide with potent anti-HIV activity.
D'Cruz OJ; Zhu Z; Yiv SH; Chen CL; Waurzyniak B; Uckun FM
Contraception; 1999 May; 59(5):319-31. PubMed ID: 10494486
[TBL] [Abstract][Full Text] [Related]
16. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa.
Niruthisard S; Roddy RE; Chutivongse S
Sex Transm Dis; 1991; 18(3):176-9. PubMed ID: 1658953
[TBL] [Abstract][Full Text] [Related]
17. Clinical development of microbicides for the prevention of HIV infection.
D'Cruz OJ; Uckun FM
Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of vaginally administered nonoxynol-9 in premenopausal women.
Barditch-Crovo P; Witter F; Hamzeh F; McPherson J; Stratton P; Alexander NJ; Trapnell CB
Contraception; 1997 Apr; 55(4):261-3. PubMed ID: 9179459
[TBL] [Abstract][Full Text] [Related]
19. Contraception and the prevention of sexually transmitted diseases.
Kirkman R; Chantler E
Br Med Bull; 1993 Jan; 49(1):171-81. PubMed ID: 8324607
[TBL] [Abstract][Full Text] [Related]
20. Boost for vaginal microbicides against HIV.
Lange JM; Karam M; Piot P
Lancet; 1993 Nov; 342(8883):1356. PubMed ID: 7901643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
